References

1. Immunology. Chapter 1: Innate (non-specific) immunity. In: Microbiology and Immunology On-line. University of South Carolina website. http://pathmicro.med.sc.edu/ghaffar/innate.htm. Accessed July 10, 2008.
2. Sompayrac L. How the Immune System Works. 3rd ed. Malden, MA: Blackwell Publishing; 2008.
3. Medzhitov R. The intersection of innate and adaptive immunity. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;427-450.
4. Yokoyama WM. Natural killer cells. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;483-517.
5. Part I. An introduction to immunobiology and innate immunity. In: Janeway CA, Travers P, Walport M, Shlomchik M, eds. Immunobiology. http://www.ncbi.nlm.nih.gov/books/bv.fcgi ?highlight=natural,killer&rid=imm.section.203#221. Accessed July 14, 2008.
6. Paul WE. The immune system. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;1-26.
7. Flajnik MF, Du Pasquier L. Evolution of the immune system. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;56-124.
8. Hardy RR. B lymphocyte development and biology. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;237-269.
9. Immunology. Chapter 4: Immunoglobulins: structure and function. In: Microbiology and Immunology On-line. University of South Carolina website. http://pathmicro.med.sc.edu/mayer/IgStruct2000.htm. Accessed
   July 10, 2008.
10. Reiner SL. Peripheral T lymphocyte response and function. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;407-425.
    
11. Vignali D. How many mechanisms do regulatory T cells need? Eur J Immunol. 2008;38:908-911.
12. Davis MM, Chien Y-H. T-cell antigen receptors. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;313-345.
13. Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by γδ T-cells. Science. 2001;294:605-609.
14. Kimball JW. B-cells and T-cells. In: Kimball's Biology Pages. http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/B/B_and_Tcells.html#Gamma_Delta. Accessed
    July 9, 2008.
15. Tanaka Y. Human γδ T-cells and tumor immunotherapy. J Clin Exp Hematopathol. 2006;46:11-23.
16. Guermonprez P, Amigorena S. Pathways for antigen cross-presentation. Springer Semin Immunopathol. 2005;26:257-271.
17. Ochsenbein AF. Principles of tumor immunosurveillance and implications for immunotherapy. Cancer Gene Ther. 2002;9:1043-1055.
18. Immunology. Chapter 11: Response to antigen: processing and presentation. In: Microbiology and Immunology On-line. University of South Carolina Web site. http://pathmicro.med.sc.edu/bowers/ant-pres.htm. Accessed July 7, 2008.


19. Rothenberg EV, Yui MA. Development of T-cells. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;376-406.
20. Ehrlich P. Ueber den jetzigen Stand der Karzinomforschung. Ned Tijdschr Geneeskd. 1909;5(part 1):273-290.
21. Decker JM. Tumor immunology. The University of Arizona website. http://www.microvet.arizona.edu/Courses/MIC419/Tutorials/tumor.html. Accessed July 9, 2008.
22. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329-360.
23. Mihm MC Jr, Clemente CG, Cascinelli M. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
    Lab Invest. 1996;74:43-47.
24. Bulkley GB, Cohen MH, Banks PM, Char DH, Ketcham AS. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile. Cancer. 1975;36:485-494.
25. Restifo R, Robbins PF, Rosenberg SA. Tumor immunology. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003;1489-1522.
26. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380-384.
27. Hodi FS. Well-defined melanoma antigens as progression markers for melanoma: insights into differential expression and host response based on stage. Clin Cancer Res. 2006;12:673-678.
28. Part V. The immune system in health and disease. In: Janeway CA, Travers P, Walport M, Shlomchik M, eds. Immunobiology. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=tumor&rid=imm.section.2184#2187. Accessed July 10, 2008.
29. p53 mutations and cancer. The TP53 website. http://p53.free.fr/Database/p53_cancer_db.html. Accessed July 13, 2008.
30. Kunkel D. Human T-cell attacking fibroblast tumor cells (SEM x 4000). Dennis Kunkel Microscopy, Inc website. http://www.denniskunkel.com. Accessed July 14, 2008.
31. Goedegebuure PS. Eberlein TJ. The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol Res. 1995;14:119-131.
32. Dudley ME, Rosenberg SA. Adoptive cell transfer therapy. Semin Oncol. 2007;34:524-531.
33. Chiari R, Hames G, Stroobant V, et al. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T-cells on HLA class II molecules. Cancer Res. 2000;60:4855-4863.
34. Pavoni E, Monteriu G, Santapaola D, et al. Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. BMC Biotechnology. 2007;7:70.
35. Kim PS, Armstrong TD, Song H, et al. Antibody association with HER-2/neu-targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs. J Clin Invest. 2008;118:1700-1711.